ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 82 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 1.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $367,000 | -19.3% | 50,853 | 0.0% | 0.00% | – |
Q4 2021 | $455,000 | -86.0% | 50,853 | -45.0% | 0.00% | -100.0% |
Q3 2021 | $3,242,000 | +40.0% | 92,467 | 0.0% | 0.00% | +50.0% |
Q2 2021 | $2,315,000 | +50.0% | 92,467 | +270.1% | 0.00% | 0.0% |
Q1 2021 | $1,543,000 | +78.6% | 24,985 | +20.8% | 0.00% | +100.0% |
Q4 2020 | $864,000 | – | 20,687 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
CM Management, LLC | 275,000 | $825,000 | 0.88% |
Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
Diametric Capital, LP | 200,000 | $600,000 | 0.25% |